Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Eur Respir J ; 27(3): 585-93, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16507860

ABSTRACT

Recently, granulocyte-macrophage colony-stimulating factor (GM-CSF) auto-antibodies have been found in many patients with pulmonary alveolar proteinosis (PAP). The present study reports a retrospective case series of patients who used aerosolised GM-CSF in the treatment of idiopathic PAP. Between 1999 and 2003, 12 patients elected to receive aerosolised GM-CSF (250 microg b.i.d. every other week) in lieu of whole-lung lavage or observation. Patient characteristics, pulmonary function tests, arterial blood gas analysis, laboratory values and chest radiographs were extracted from the patient's medical records. Of the six patients tested, all had GM-CSF neutralising antibodies. Additionally, abnormalities in GM-CSF gene expression (one patient), receptor expression (two patients) and ability to upregulate adhesion molecules (one patient) were found. All patients except one had a positive response (mean improvements in arterial oxygen tension, alveolar-arterial oxygen gradient, carbon monoxide diffusing capacity of the lung and forced vital capacity were 17.1 mmHg, 18.4 mmHg, 16.6% pred and 13.5% pred, respectively). Two patients made a complete recovery and were disease free 1 and 2 yrs after discontinuing treatment. Four patients showed complete response to both the initial course or when treated again for recurrence after discontinuation of treatment. One patient required dose escalation (500 microg b.i.d.) with complete response. GM-CSF was well tolerated without late toxicity after median (range) follow-up of 30.5 (3-68) months. In conclusion, aerosolised granulocyte-macrophage colony-stimulating factor is safe and effective in treating pulmonary alveolar proteinosis providing an alternative to whole-lung lavage or subcutaneous granulocyte-macrophage colony-stimulating factor.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage , Pulmonary Alveolar Proteinosis/drug therapy , Administration, Inhalation , Adult , Female , Humans , Male , Middle Aged , Retrospective Studies
2.
Pediatr Cardiol ; 27(1): 137-139, 2006.
Article in English | MEDLINE | ID: mdl-16078121

ABSTRACT

Coarctation of the aorta is a relatively common congenital condition. Most infantile presentations of aortic coarctation are related to the associated congenital cardiac abnormalities leading to congestive heart failure or systemic hypoperfusion. We describe a 4-month-old infant who presented with stridor as the sole manifestation of coarctation. Radiologic studies revealed enlarged innominate artery due to the aortic coarctation that resulted in tracheal compression. After surgical correction, respiratory signs and symptoms completely resolved. This case report describes a unique cause of stridor in newborn infants and discusses the potential for vascular anomalies to result in tracheal narrowing.


Subject(s)
Aortic Coarctation/diagnosis , Brachiocephalic Trunk/abnormalities , Respiratory Sounds/etiology , Tracheal Stenosis/diagnosis , Aortic Coarctation/complications , Aortic Coarctation/surgery , Aortic Valve/abnormalities , Brachiocephalic Trunk/surgery , Bronchoscopy , Diagnosis, Differential , Ductus Arteriosus, Patent/diagnosis , Follow-Up Studies , Humans , Infant , Male , Tomography, X-Ray Computed , Tracheal Stenosis/surgery
3.
J Thorac Cardiovasc Surg ; 122(1): 169-77, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11436051

ABSTRACT

OBJECTIVE: We and others have observed significant hyperinflation and airflow obstruction after the surgical repair of pulmonary atresia and ventricular septal defect. This study sought to objectively characterize this problem and determine the prevalence of airway hyperresponsiveness in these patients. METHODS: We performed a prospective study of children and young adults with pulmonary atresia and ventricular septal defect between June 1996 and December 1998. The participants were stratified into 2 distinct molecular genotypes on the basis of chromosome 22q11.2 microdeletion. A clinical diagnosis of asthma and an objective assessment of airway hyperresponsiveness were determined by means of an asthma inventory scale and methacholine challenge testing, respectively. Thirty-three patients were enrolled. Thirteen had velocardiofacial syndrome, each with chromosome 22q11.2 microdeletion. RESULTS: None of the nonsyndromic patients had evidence for haploinsufficiency. Overall, 66.7% (22/33) met criteria for a clinical diagnosis of airway hyperresponsiveness: 62% (8/13) from the microdeletion genotype and 70% (14/20) from the nonsyndromic group. CONCLUSIONS: We have identified an extremely strong association between pulmonary atresia and ventricular septal defect and persistent airway hyperresponsiveness. Haploinsufficiency at chromosome 22q11.2 did not contribute to this predilection for airway hyperresponsiveness. These results provide a basis to anticipate persistent respiratory difficulties after operations in patients with pulmonary atresia and ventricular septal defect. Moreover, this at-risk patient population may yield unique insights into fundamental mechanisms involved in the pathogenesis of airway hyperresponsiveness.


Subject(s)
Bronchial Hyperreactivity/complications , Heart Septal Defects, Ventricular/complications , Pulmonary Atresia/complications , Adolescent , Adult , Bronchial Hyperreactivity/genetics , Bronchial Hyperreactivity/physiopathology , Bronchial Provocation Tests , Child , Chromosome Deletion , Female , Genotype , Humans , Male , Prospective Studies , Pulmonary Atresia/genetics , Spirometry
4.
Life Sci ; 69(4): 455-67, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11459436

ABSTRACT

We sought to delineate contributions of nitric oxide (NO) and other mechanisms to impairment of contraction and endothelium-dependent relaxation following prolonged in vitro incubation, endotoxin and interleukin-1 exposure in isolated rat aorta. Responses from freshly-dissected (control) rings +/-endothelium were compared with those from rings incubated in sterile, antibiotic containing medium +/- E. Coli endotoxin (LPS, 100 microg/ml) +/- interleukin-1 (IL-1, 40 ng/ml) at 37 degrees C for 20-24 h. In some experiments, medium included dexamethasone (DEX, 1 microg/ml), cycloheximide (10 microg/ml), or N(G)-nitro-L-arginine (NNLA, 10(-4)M). After incubation, medium nitrite was measured. Incubation alone, without addition of inflammatory mediators, impaired contraction in an agonist-specific manner, by both NO-dependent and NO-independent mechanisms. Either LPS or IL-1 diminished contraction further, in a similarly heterogeneous manner. For example, contractions were changed in LPS-incubated endothelium-intact rings (vs. fresh controls) by -85%, +115%, -15%, -96%, and -37% for phenylephrine (PE), serotonin, prostaglandin F2alpha, angiotensin II, and U46619, respectively. NO synthase inhibition with NNLA either following, or during LPS incubation only partially normalized subsequent PE contractions, an effect which was smaller than that of DEX. Nitrite accumulation was inversely proportional to PE response, even though NO was not the sole mediator of LPS-impaired contraction. LPS and IL-1 nearly abolished ACh-induced relaxation, which was only mildly impaired by incubation alone. We conclude that prolonged incubation impaired vasoconstriction via both NO synthase induction and NO-independent mechanisms. LPS or IL-1 incubation impaired vasoconstriction further, primarily by NO-independent mechanisms. Moreover, vasoconstrictor responses following LPS varied with the agonist's ability to modulate endothelial NO release. These results are in accord with the failure of NO synthase inhibition to fully restore systemic vascular resistance indices in experimental endotoxemia or in hyperdynamic septic patients.


Subject(s)
Aorta, Thoracic/drug effects , Endotoxins/pharmacology , Nitric Oxide/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects , Animals , Aorta, Thoracic/metabolism , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/metabolism , Cycloheximide/pharmacology , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Glucocorticoids/pharmacology , In Vitro Techniques , Interleukin-1/pharmacology , Male , Nitric Oxide/metabolism , Nitrites/analysis , Nitroarginine/pharmacology , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Sprague-Dawley , Vasoconstriction/physiology , Vasoconstrictor Agents/pharmacology , Vasodilation/physiology , Vasodilator Agents/pharmacology
5.
Am J Physiol Lung Cell Mol Physiol ; 278(5): L1091-100, 2000 May.
Article in English | MEDLINE | ID: mdl-10781442

ABSTRACT

We previously demonstrated that after several days of serum deprivation about one-sixth of confluent cultured canine tracheal myocytes acquire an elongated, structurally and functionally contractile phenotype. These myocytes demonstrated significant shortening on ACh exposure. To evaluate the mechanism by which these myocytes acquire responsiveness to ACh, we assessed receptor-Ca(2+) coupling using fura 2-AM fluorescence imaging and muscarinic receptor expression using Western analysis. Cells were grown to confluence in 10% fetal bovine serum and then maintained for 7-13 days in serum-free medium. A fraction of serum-deprived cells exhibited reproducible intracellular Ca(2+) mobilization in response to ACh that was uniformly absent from airway myocytes before serum deprivation. The Ca(2+) response to 10(-4) M ACh was ablated by inositol 1,4,5-trisphosphate (IP(3)) receptor blockade using 10(-6) M xestospongin C but not by removal of extracellular Ca(2+). Also, 10(-7) M atropine or 10(-7) M 4-diphenylacetoxy-N-methylpiperidine completely blocked the response to ACh, but intracellular Ca(2+) mobilization was not ablated by 10(-6) M pirenzepine or 10(-6) M methoctramine. In contrast, 10(-5) M bradykinin (BK) was without effect in these ACh-responsive myocytes. Interestingly, myocytes that did not respond to ACh demonstrated robust increases in intracellular Ca(2+) on exposure to 10(-5) M BK that were blocked by removal of extracellular Ca(2+) and were only modestly affected by IP(3) receptor blockade. Serum deprivation increased the abundance of M(3) receptor protein and of BK(2) receptor protein by two- to threefold in whole cell lysates within 2 days of serum deprivation, whereas M(2) receptor protein fell by >75%. An increase in M(3) receptor abundance and restoration of M(3) receptor-mediated Ca(2+) mobilization occur concomitant with reacquisition of a contractile phenotype during prolonged serum deprivation. These data demonstrate plasticity in muscarinic surface receptor expression and function in a subpopulation of airway myocytes that show mutually exclusive physiological and pharmacological diversity with other cells in the same culture.


Subject(s)
Calcium/metabolism , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Receptors, Muscarinic/metabolism , Trachea/cytology , Acetylcholine/pharmacology , Animals , Atropine/pharmacology , Blood Proteins/pharmacology , Blotting, Western , Bradykinin/pharmacology , Calcium Channels/metabolism , Cells, Cultured , Diamines/pharmacology , Dogs , Dose-Response Relationship, Drug , Fluorescent Dyes , Fura-2 , Inositol 1,4,5-Trisphosphate Receptors , Macrocyclic Compounds , Muscarinic Antagonists/pharmacology , Muscle, Smooth/chemistry , Oxazoles/pharmacology , Parasympatholytics/pharmacology , Phenotype , Piperidines/pharmacology , Pirenzepine/pharmacology , Receptor, Muscarinic M3 , Receptors, Bradykinin/analysis , Receptors, Bradykinin/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Muscarinic/analysis , Trachea/chemistry , Trachea/metabolism , Vasodilator Agents/pharmacology
7.
Clin Cancer Res ; 5(9): 2316-23, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10499599

ABSTRACT

The objective was to study the feasibility of granulocyte macrophage-colony stimulating factor (GM-CSF) delivery to the lung using an aerosol in humans. A Phase I dose escalation study provided GM-CSF at three dose levels as a twice-a-day (BID) x 7 days schedule. Pulmonary functions were monitored using a remote spirometry device. Blood counts were checked at the beginning and end of each week of GM-CSF nebulization. If no toxicity was encountered, patients rested for 7 days and then were treated at the next dose level. Six of seven patients were successfully dose escalated from 60 microg/dose BID x 7 days, to 120 microg/dose BID x 7 days, then 240 microg/dose BID x 7 days. No toxicity was seen. Comparison of day 0 and day 7 blood leukocyte counts showed no significant increases in either leukocyte numbers or percentage of neutrophils. Pulmonary functions test changes were minor. No significant change in forced vital capacity, FEV1, peak flow, or FEF 25-75 related to either time or dose level was observed. One patient's lung metastases progressed. The other five patients received an additional 2-6 months of intermittent aerosol GM-CSF at dose level 3 without side effects. One patient with Ewing's sarcoma has a complete response, and a patient with melanoma had a partial response; the other three had stabilization of pulmonary metastases for 2-6 months. Aerosol delivery of GM-CSF is feasible, safe, and possibly effective. Aerosol cytokine delivery may achieve effective immunological activation against cancer in the lung and is worthy of further study.


Subject(s)
Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage , Granulocyte-Macrophage Colony-Stimulating Factor/adverse effects , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Administration, Inhalation , Adult , Aerosols , Aged , Antineoplastic Agents/therapeutic use , Blood Cell Count/drug effects , Dose-Response Relationship, Drug , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Humans , Lung Neoplasms/physiopathology , Middle Aged , Respiratory Function Tests
8.
Am J Physiol ; 276(1): L197-206, 1999 01.
Article in English | MEDLINE | ID: mdl-9887072

ABSTRACT

We tested the hypothesis that prolonged serum deprivation would allow a subset of cultured airway myocytes to reacquire the abundant contractile protein content, marked shortening capacity, and elongated morphology characteristic of contractile cells within intact tissue. Passage 1 or 2 canine tracheal smooth muscle (SM) cells were grown to confluence, then serum deprived for up to 19 days. During serum deprivation, two differentiation pathways emerged. One-sixth of the cells developed an elongated morphology and aligned into bundles. Elongated myocytes contained cables of contractile myofilaments, dense bodies, gap junctions, and membrane caveoli, ultrastructural features of contractile SM in tissue. These cells immunostained intensely for SM alpha-actin, SM myosin heavy chain (MHC), and SM22 (an SM-specific actin-binding protein), and Western analysis of culture lysates disclosed 1.8 (SM alpha-actin)-, 7.7 (SM MHC)-, and 5.8 (SM22)-fold protein increases during serum deprivation. Immunoreactive M3 muscarinic receptors were present in dense foci distributed throughout elongated, SM MHC-positive myocytes. ACh (10(-3) M) induced a marked shortening (59.7 +/- 14.4% of original length) in 62% of elongated myocytes made semiadherent by gentle proteolytic digestion, and membrane bleb formation (a consequence of contraction) occurred in all stimulated cells that remained adherent and so did not shorten. Cultured airway myocytes that did not elongate during serum deprivation instead became short and flattened, lost immunoreactivity for contractile proteins, lacked the M3 muscarinic-receptor expression pattern seen in elongated cells, and exhibited no contractile response to ACh. Thus we demonstrate that prolonged serum deprivation induces distinct differentiation pathways in confluent cultured tracheal myocytes and that one subpopulation acquires an unequivocally functional contractile phenotype in which structure and function resemble contractile myocytes from intact tissue.


Subject(s)
Muscle Contraction/physiology , Muscle, Smooth/cytology , Muscle, Smooth/physiology , Trachea/cytology , Trachea/physiology , Animals , Blotting, Western , Cell Communication/physiology , Cell Differentiation/physiology , Cells, Cultured , Contractile Proteins/metabolism , Culture Media, Serum-Free , Cytoplasm/physiology , Dogs , Immunohistochemistry , In Vitro Techniques , Muscle Proteins/metabolism , Muscle, Smooth/ultrastructure , Receptors, Muscarinic/metabolism , Trachea/ultrastructure
9.
Kidney Int ; 54(4): 1063-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9767522

ABSTRACT

BACKGROUND: We hypothesized that endotoxin (LPS) would impair bradykinin (BK)-induced calcium (Ca2+) mobilization in aortic endothelial cells, perhaps due to cytotoxicity or via stimulation of nitric oxide (NO) synthesis. As well, we sought to define contributions of LPS-stimulated Ca2+ mobilization to these effects. METHODS: LPS- or BK-induced increments of intracellular Ca2+ were assessed by microspectrofluorimetry with fura-2 in passaged bovine aortic endothelial cells. Time- and dose-dependent effects of LPS exposure (+/- inhibitors of NO or prostaglandin synthesis) on subsequent BK-induced Ca2+ mobilization and on attached cell counts were determined. RESULTS: LPS (0.1 to 1.0 mg/ml) led to rapid increments of Ca2+, while Ca2+ responses were delayed following LPS (1 to 10 microg/ml) and lower doses were without effect. By contrast, LPS more potently (1.0 pg to 1.0 microg/ml) led to dose- and time-dependent impairment of subsequent BK-induced Ca2+ mobilization, with peak effect at four to six hours, persisting for at least 18 hours. This delayed effect on BK-response was unaltered by inhibition of either NO synthase or cyclooxygenase. The effect of LPS on BK-responsivity depended importantly on cell confluence, as it was not observed in subconfluent cells. By contrast, LPS-induced cell detachment, which was observed only at doses > or = 1.0 microg/ml, did not depend on confluence. CONCLUSIONS: Different mechanisms lead to endothelial cytotoxicity and to impaired BK-response following LPS. Only the former effect, occurring at higher doses, might depend on initial LPS-induced Ca2+ mobilization.


Subject(s)
Calcium Signaling/drug effects , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Lipopolysaccharides/toxicity , Animals , Bradykinin/pharmacology , Cattle , Cells, Cultured , Cyclooxygenase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Indomethacin/pharmacology , Kinetics , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type III , Signal Transduction/drug effects
10.
Am J Physiol ; 274(6): L997-L1005, 1998 06.
Article in English | MEDLINE | ID: mdl-9609739

ABSTRACT

Previous studies in vivo or in isolated airway preparations have suggested that eosinophil-derived polycationic proteins enhance airway smooth muscle tone in an epithelium-dependent manner. We assessed the direct effects of activated human eosinophil supernatant, major basic protein (MBP), and polycationic polypeptides on basal and agonist-stimulated intracellular Ca2+ concentrations ([Ca2+]i) in cultured bovine tracheal smooth muscle (TSM) cells. A 1-h incubation of myocytes with activated eosinophil buffer resulted in a doubling of basal [Ca2+]i and increased responsivity to histamine compared with myocytes that were exposed to sham-activated eosinophil buffer. In addition, concentration-dependent acute transient increases and subsequent 1-h sustained elevations of basal [Ca2+]i were observed immediately after addition of MBP and model polycationic proteins. Finally, both peak and plateau [Ca2+]i responses to bradykinin addition were augmented significantly in cultured myocytes that had been exposed to low concentrations of MBP or model polycationic proteins but were inhibited at greater concentrations. This elevated [Ca2+]i to polycationic proteins was manifest in epithelium-denuded bovine TSM strips as concentration-dependent increased basal tone. We conclude that activated eosinophil supernatant, MBP, and other polycationic proteins have a direct effect on both basal and subsequent agonist-elicited Ca2+ mobilization in cultured TSM cells; TSM strips in vitro demonstrated, respectively, augmented and diminished responses to the contractile agonist acetylcholine. It is possible that alteration in myocyte Ca2+ mobilization induced by these substances may influence clinical states of altered airway tone, such as asthma.


Subject(s)
Blood Proteins/physiology , Calcium/metabolism , Eosinophils/physiology , Peptides/pharmacology , Polyamines , Ribonucleases , Trachea/metabolism , Acetylcholine/pharmacology , Animals , Bradykinin/pharmacology , Cattle , Eosinophil Granule Proteins , Histamine/pharmacology , Humans , Inflammation Mediators , Muscle, Smooth/metabolism , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Polyelectrolytes
11.
J Lab Clin Med ; 131(4): 336-43, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9579387

ABSTRACT

We hypothesized that endotoxin (LPS) would impair vasoconstrictor-agonist-induced calcium (Ca2+) mobilization by a nitric oxide (NO)-dependent mechanism. We incubated bovine aortic myocytes (passages 16 to 23) for 22 to 24 hours with 0 to 1.0 mg/ml Escherichia coli lipopolysaccharide (LPS). Medium (Dulbecco's modified Eagle's medium (DMEM) + 10% fetal bovine serum (FBS)) was assayed for nitrite (chemiluminescence), and myocytes were loaded with fura-2 acetoxymethyl ester (fura-2AM), after which we assessed basal and thrombin (10 U/ml)-induced peak Ca2+ mobilization by microspectrofluorimetry. LPS (0.01 to 1.0 mg/ml) led to dose-dependent nitrite accumulation, which was blocked by coincubation with N(omega)-nitro-L-arginine methyl ester (L-NAME, 1 mmol/L). LPS also impaired Ca2+ responses in a dose-dependent manner (from -13% at 0.1 mg/ml to -47% at 1.0 mg/ml, n = 8 to 43/dose). However, coincubation with L-NAME did not ameliorate the Ca2+ mobilization defect (peak Ca2+ increments: control = 419 +/-30 nmol/L, vs LPS (1 mg/ml) = 206+/-18 nmol/L (mean+/-SE), n = 15; p < 0.001; control/L-NAME: 417+/-31 nmol/L vs LPS/L-NAME: 212+/-19 nmol/L; n = 17 p < 0.001), despite inhibition of associated nitrite accumulation in the medium (control vs LPS: p < 0.001; control/L-NAME vs LPS/L-NAME: p > 0.05; LPS vs LPS/L-NAME: p < 0.001). Supplemental L-arginine augmented LPS-induced nitrite generation without affecting Ca2+ mobilization. Indomethacin failed to prevent the LPS-induced decrement in thrombin response, but did inhibit LPS-induced myocyte nitrite production, suggesting "crosstalk" between the NO-synthase and cyclo-oxygenase (COX) systems. These experiments suggest that LPS-induced vascular contractile impairment is at least partly mediated by an NO-independent impairment of agonist-induced myocyte Ca2+ mobilization. This further suggests that any important contribution of NO synthesis to LPS-induced contractile dysfunction must depend on impairment of the Ca2+ sensitivity of the contractile apparatus (i.e., pharmacomechanical coupling).


Subject(s)
Aorta/drug effects , Calcium/metabolism , Endothelium, Vascular/drug effects , Lipopolysaccharides/pharmacology , Nitric Oxide/metabolism , Animals , Aorta/metabolism , Aorta/physiology , Arginine/pharmacology , Cattle , Cells, Cultured , Cyclooxygenase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiology , Enzyme Induction , Enzyme Inhibitors/pharmacology , Muscle Relaxation , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis
12.
J Pediatr ; 132(3 Pt 1): 540-3, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9544919

ABSTRACT

We report a case of acute eosinophilic pneumonia associated with adult respiratory distress syndrome in an adolescent. This entity should be considered in the differential diagnosis in previously well children and adolescents who are seen with unexplained respiratory failure and who have many eosinophils in bronchoalveolar lavage fluid. Prompt recognition of this rapidly reversible noninfectious disorder and institution of corticosteroids may be lifesaving.


Subject(s)
Pulmonary Eosinophilia/complications , Respiratory Distress Syndrome/etiology , Acute Disease , Adolescent , Bronchoalveolar Lavage Fluid , Glucocorticoids/therapeutic use , Humans , Male , Methylprednisolone/therapeutic use , Pulmonary Eosinophilia/pathology , Pulmonary Eosinophilia/therapy , Respiration, Artificial
13.
Am J Respir Crit Care Med ; 156(6): 1846-54, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9412565

ABSTRACT

We hypothesized that endotoxin would impair agonist-induced calcium (Ca2+) mobilization in rat mesangial cells, owing to the induction of nitric oxide synthase (NOS) and augmented nitric oxide (NO) synthesis. We measured basal and bradykinin-induced peak free cytosolic Ca2+ concentrations through microspectrofluorimetry with fura-2 in confluent mesangial cells, and assayed conditioned medium for nitrite accumulation. Prior to measurement, cells were incubated overnight in serum-supplemented medium, with or without endotoxin, 1-arginine, indomethacin, meclofenamate, or N omega-nitro-L-arginine methyl ester (L-NAME). Endotoxin (1 mg/ml) decreased bradykinin-induced peak Ca2+ responses by 35 to 60% (p < 0.0001) and increased nitrite accumulation > 6-fold (p < 0.01). Arginine supplementation further (> 9-fold, p < 0.0001) increased nitrite accumulation without changing the effect on Ca2+. Inhibition of NOS abolished increments in nitrite concentration but had no effect on impaired Ca2+ responses. Cyclooxygenase (COX) inhibitors, present during incubation with endotoxin, but not afterward, normalized bradykinin-stimulated calcium responses. Thrombin-stimulated Ca2+ responses were similarly affected. We conclude that neither NO nor prostaglandins act directly to impair agonist-induced Ca2+ mobilization following endotoxin exposure; however, this effect may be an indirect effect of COX products, including reactive oxygen intermediates.


Subject(s)
Endotoxins/pharmacology , Glomerular Mesangium/metabolism , Animals , Arginine/pharmacology , Bradykinin/pharmacology , Cell Survival , Cells, Cultured , Culture Media, Conditioned , Cyclooxygenase Inhibitors/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Escherichia coli , Glomerular Mesangium/cytology , Indomethacin/pharmacology , Lipopolysaccharides/pharmacology , Meclofenamic Acid/pharmacology , Microspectrophotometry , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/physiology , Nitrites/metabolism , Rats , Thrombin/pharmacology
14.
Clin Infect Dis ; 25(3): 630-3, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9314451

ABSTRACT

We report the case of a 14-year-old boy with granulomatous pneumonia caused by Francisella tularensis. In addition, an autosomal recessive form of chronic granulomatous disease was diagnosed. Both F. tularensis and chronic granulomatous disease are associated with pulmonary granulomas. To our knowledge, this is the first report of F. tularensis infection in a patient with chronic granulomatous disease. The relationship between these two processes is discussed.


Subject(s)
Granulomatous Disease, Chronic/complications , Pneumonia, Bacterial/complications , Tularemia/complications , Adolescent , Anti-Bacterial Agents , Drug Therapy, Combination/therapeutic use , Francisella tularensis/immunology , Genes, Recessive , Granulomatous Disease, Chronic/genetics , Granulomatous Disease, Chronic/immunology , Humans , Male , NADPH Oxidases , Neutrophils/immunology , Neutrophils/physiology , Phosphoproteins/deficiency , Phosphoproteins/genetics , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/immunology , Tularemia/drug therapy , Tularemia/immunology
15.
J Pediatr ; 130(2): 217-24, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9042123

ABSTRACT

OBJECTIVES: To assess the effects of breathing a low-density gas mixture on dyspnea and the pulsus paradoxus in children with status asthmaticus. DESIGN: In an urban academic tertiary referral center, 18 patients, aged 16 months to 16 years, who were being treated for status asthmaticus with continuously inhaled beta-agonist and intravenously administered methylprednisolone and had a pulsus paradoxus of greater than 15 mm Hg received either an 80%:20% helium-oxygen gas mixture (HELIOX patients) or room air (control patients) at 10 L/min by nonrebreathing face mask in a double-blind, randomized, controlled trial. In all patients, baseline data, including pulsus paradoxus (determined by sphygmomanometer or arterial catheter blood pressure readings), respiratory rate, heart rate, investigator-scored dyspnea index, and oxygen saturation, were compared with values obtained 15 minutes during and after intervention. In a subset of patients, peak flows before and after breathing HELIOX or room air were measured. When clinically indicated, arterial blood gases were obtained. RESULTS: The pulsus paradoxus (in millimeters of mercury) fell significantly from an initial mean value of 23.3 +/- 6.8 to 10.6 +/- 2.8 with HELIOX breathing (p < 0.001) and increased again to 18.5 +/- 7.3 after cessation of HELIOX. Peak flow increased 69.4% +/- 12.8% during HELIOX breathing (p < 0.05). The dyspnea index decreased from an initial mean value of 5.7 +/- 1.3 to 1.9 +/- 1.7 with HELIOX breathing (p < 0.0002) and increased again to 4.0 +/- 0.5 after cessation of HELIOX breathing. In control patients, there was no significant difference in pulsus paradoxus or dyspnea index at any time during the study period. Mechanical ventilation was averted in three patients in whom dyspnea lessened dramatically during breathing of HELIOX. CONCLUSION: During acute status asthmaticus, inhaled HELIOX significantly lowered the pulsus paradoxus, increased peak flow, and lessened the dyspnea index. Moreover, HELIOX spared three patients a planned intubation and caused no apparent side effects. Thus HELIOX reduces the work of breathing and may forestall respiratory failure in children with status asthmaticus, thus preventing the need for mechanical ventilation.


Subject(s)
Helium/administration & dosage , Oxygen/administration & dosage , Status Asthmaticus/drug therapy , Administration, Inhalation , Adolescent , Analysis of Variance , Child , Child, Preschool , Double-Blind Method , Female , Humans , Infant , Male , Pulse/drug effects , Statistics, Nonparametric , Status Asthmaticus/blood , Status Asthmaticus/physiopathology , Work of Breathing/drug effects
16.
Am J Respir Crit Care Med ; 153(6 Pt 1): 1985-7, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8665066

ABSTRACT

We present the effects of abrupt discontinuation of inhaled nitric oxide (NO) in four patients with severe hypoxemic respiratory failure. These patients ranged from 9 mo to 65 yr of age. In each patient, after the initiation of inhaled NO, a marginal, but immediate, beneficial effect on gas exchange and, when measured, a reduction in pulmonary artery pressures was noted. However, during attempts to discontinue inhaled NO, not only did these patients develop worsening oxygenation and recrudescence of pulmonary hypertension but, unexpectedly, these parameters were worse than the baseline values, leading to life-threatening hemodynamic instability. These effects reversed immediately after reinstitution of inhaled NO. The mechanism of this severe ¿rebound¿ in pulmonary hypertension after abrupt withdrawal of NO is unclear, but its existence emphasizes the need to avoid a substantial risk to these patients. Moreover, we believe that both unintentional and intentional termination of inhaled NO therapy may lead to life-threatening deterioration in gas exchange and circulatory hemodynamics that exceeds the initial therapeutic benefit.


Subject(s)
Hemodynamics/drug effects , Hypertension, Pulmonary/chemically induced , Hypoxia/chemically induced , Nitric Oxide/adverse effects , Respiratory Insufficiency/therapy , Substance Withdrawal Syndrome , Vasodilator Agents/adverse effects , Administration, Inhalation , Adult , Aged , Female , Humans , Hypoxia/complications , Infant , Male , Nitric Oxide/administration & dosage , Respiratory Insufficiency/etiology , Vasodilator Agents/administration & dosage
18.
J Appl Physiol (1985) ; 76(2): 743-9, 1994 Feb.
Article in English | MEDLINE | ID: mdl-8175585

ABSTRACT

Recently, we demonstrated that chronic exposure to hyperoxia causes in vivo airway muscarinic receptor hyperresponsiveness in the developing rat [Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L263-L269, 1992]. To test whether airway cholinergic hyperresponsiveness might result from intrinsic alterations in smooth muscle contractility, we measured the effect of in vivo hyperoxia on the contractile force elicited by acetylcholine (ACh) of isometrically mounted tracheal rings in vitro. Tracheal rings were obtained from 3-wk-old rats exposed to air or to > 95% O2 for 8 days. Muscarinic responses were determined by measuring the force elicited by exposure to increasing concentrations of ACh. Responses were normalized to the morphometrically determined tracheal smooth muscle cross-sectional area in a plane perpendicular to the axis of force generation. In vivo O2 exposure significantly increased maximal ACh-induced stress generation (response to 10(-3) M ACh: air, 15.92 +/- 1.37 g/mm2; O2, 21.78 +/- 1.52 g/mm2; P = 0.010). The ACh-induced stress generation of cylinders from hyperoxic rats was substantially reduced by both epithelial removal and treatment with the cyclooxygenase inhibitor indomethacin. We conclude that in vivo hyperoxic exposure increases tracheal smooth muscle contractile function in vitro and that epithelium-derived prostaglandin(s) contributes to the observed increase in maximal contractile responsiveness.


Subject(s)
Muscle, Smooth/physiopathology , Oxygen/metabolism , Respiratory Hypersensitivity/etiology , Trachea/physiopathology , Animals , Animals, Newborn , Culture Techniques , Cyclooxygenase Inhibitors/pharmacology , Lipoxygenase Inhibitors , Mucous Membrane/physiology , Muscle Contraction , Rats , Rats, Sprague-Dawley , Stress, Mechanical
19.
Am Rev Respir Dis ; 148(6 Pt 1): 1638-45, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8256913

ABSTRACT

In order to determine whether endotoxemia induced generalized defects in vascular contraction and endothelium-dependent relaxation, we studied the effect of in vivo endotoxin administration in Sprague-Dawley rats and New Zealand White rabbits on endothelial and arterial smooth-muscle responses of isolated thoracic aorta in vitro. Endotoxin treatment significantly decreased contractile responses to phenylephrine (PE), angiotensin II (AII), serotonin (5-HT), and potassium chloride. This effect was not altered by indomethacin or endothelial denudation. Treatment of vessels with NG-nitro-L-arginine (NNLA), an inhibitor of arginine-dependent nitric oxide biosynthesis, or with methylene blue, an inhibitor of soluble guanylate cyclase, resulted in significant improvement of the contractile defect in endotoxin-treated vessels. The restorative effect of NNLA on contractile responses in endotoxin-treated aortic rings was similar in the presence or absence of an intact endothelium. Endothelium-dependent relaxation in response to acetylcholine, substance P, or the calcium ionophore A23187 was markedly impaired in vessels from endotoxin-treated rabbits, while endothelium-independent relaxation in response to nitroprusside was similar in both groups. These results suggest that endotoxemia both induces basal, nonendothelial nitric oxide synthesis and impairs the agonist-stimulated release of endothelium-derived relaxing factor (EDRF). These findings may have mechanistic importance in the hemodynamic derangements of endotoxemia.


Subject(s)
Endothelium, Vascular/physiology , Endotoxins/pharmacology , Muscle, Smooth, Vascular/physiology , Angiotensin II/pharmacology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Arginine/analogs & derivatives , Arginine/pharmacology , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , In Vitro Techniques , Indomethacin/pharmacology , Lipopolysaccharides/pharmacology , Methylene Blue/pharmacology , Muscle, Smooth, Vascular/drug effects , Nitroarginine , Phenylephrine/pharmacology , Potassium Chloride/pharmacology , Rabbits , Rats , Rats, Sprague-Dawley , Serotonin/pharmacology , Vasoconstriction/drug effects , Vasoconstriction/physiology , Vasodilation/drug effects , Vasodilation/physiology
20.
J Pharmacol Exp Ther ; 266(3): 1475-81, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8371151

ABSTRACT

Previous in vitro studies of the human umbilical artery (HUA) have suggested that this vessel exhibits significant intrinsic tone, even in the absence of contractile agonists. Other investigators have found that these vessels are unresponsive to nitrovasodilators, suggesting that the guanylate cyclase-mediated relaxation mechanism may not be operative. To clarify these observations, human umbilical cords were obtained at the time of delivery and HUA rings were studied in organ baths. In contrast to other systemic arteries, HUA rings exhibited unstable initial tone in the absence of pharmacologic agonists. This intrinsic tone was augmented when the extracellular ionized calcium concentration was increased and abolished when extracellular calcium was removed. Rings maintained in the presence of extracellular calcium for 1 hr became less responsive to changes in extracellular calcium than did rings maintained in calcium-free buffer. Serotonin produced oscillatory, quantal contractions in the presence of calcium; in the absence of extracellular calcium, it elicited only concentration-dependent graded contractions. In the presence of nifedipine or in the absence of extracellular calcium, nitroglycerin fully relaxed contractions elicited by serotonin. Thus, in HUA, extracellular calcium produces intrinsic tone that diminishes spontaneously with time.


Subject(s)
Calcium/pharmacology , Calcium/physiology , Muscle Tonus/physiology , Umbilical Arteries/drug effects , Umbilical Arteries/physiology , Calcium/metabolism , Cell Membrane Permeability/physiology , Extracellular Space/metabolism , Female , Humans , In Vitro Techniques , Kinetics , Muscle Relaxation/drug effects , Muscle Tonus/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Potassium Chloride/pharmacology , Pregnancy , Serotonin/pharmacology , Vasoconstrictor Agents/pharmacology , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...